Panacea Pharmaceuticals, Inc. Appoints Donald A. Zelm as Vice President for Finance
(Business Wire)...``Panacea is in a position to effectively utilize Don`s financial management expertise as we continue our aggressive growth and approach the clinical trial phase for several of our drug candidates.`` About Panacea Pharmaceuticals Panacea Pharmaceuticals, Inc. focuses on developing and utilizing protein-based technologies to detect and identify changes associated with and involved in diseases of the central nervous system and cancer such as Alzheimer`s disease, brain tumors, transmissible spongiform encephalopathies, and Lewy body diseases such as Parkinson`s disease....- Jan 18 12:01 PM ET
IF the story does not appear below, Click HERE to view the text of the story!
Note: The original website is displayed below - we have no control over it and are not responsible for the content of it, we just report it! IF you click on anything below, it will take you off of our website!
Original Source: http://biz.yahoo.com/bw/010118/md_panacea_2.html
(Everything below this line is from VirtualTrials.com!)
Click HERE to return to brain tumor news headlines